42 | 64 | | |
---|
43 | 65 | | An Act relating to pharmacy benefits manage ment; |
---|
44 | 66 | | amending 36 O.S. 2021, Section 6962, as last amended |
---|
45 | 67 | | by Section 1, Chapter 293, O.S.L. 2 023 (36 O.S. Supp. |
---|
46 | 68 | | 2023, Section 6962), which relates to pharmacy |
---|
47 | 69 | | benefits manager compliance; updating statutory |
---|
48 | 70 | | reference; requiring pharmacy benefits manager to |
---|
49 | 71 | | maintain certain fiduciary duty; and providing an |
---|
50 | 72 | | effective date. |
---|
51 | 73 | | |
---|
52 | 74 | | |
---|
53 | 75 | | |
---|
54 | 76 | | |
---|
55 | 77 | | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: |
---|
56 | 78 | | SECTION 1. AMENDATORY 36 O.S. 2021, Section 6962, as |
---|
57 | 79 | | last amended by Section 1, Chapter 293, O.S.L. 2023 (36 O.S. Supp. |
---|
58 | 80 | | 2023, Section 6962), is amended to read as follows: |
---|
59 | 81 | | Section 6962. A. The Attorney General shall review and approve |
---|
60 | 82 | | retail pharmacy network access for all p harmacy benefits managers |
---|
61 | 83 | | (PBMs) to ensure compliance with Sec tion 6961 of this title. |
---|
62 | 84 | | B. A PBM, or an agent of a PBM, shall not: |
---|
63 | 85 | | 1. Cause or knowingly pe rmit the use of advertisement, |
---|
64 | 86 | | promotion, solicitation, representation, proposal or offer th at is |
---|
65 | 87 | | untrue, deceptive or misleading; |
---|
66 | 88 | | |
---|
69 | 115 | | 2 |
---|
70 | 116 | | 3 |
---|
71 | 117 | | 4 |
---|
72 | 118 | | 5 |
---|
73 | 119 | | 6 |
---|
74 | 120 | | 7 |
---|
75 | 121 | | 8 |
---|
76 | 122 | | 9 |
---|
77 | 123 | | 10 |
---|
78 | 124 | | 11 |
---|
79 | 125 | | 12 |
---|
80 | 126 | | 13 |
---|
81 | 127 | | 14 |
---|
82 | 128 | | 15 |
---|
83 | 129 | | 16 |
---|
84 | 130 | | 17 |
---|
85 | 131 | | 18 |
---|
86 | 132 | | 19 |
---|
87 | 133 | | 20 |
---|
88 | 134 | | 21 |
---|
89 | 135 | | 22 |
---|
90 | 136 | | 23 |
---|
91 | 137 | | 24 |
---|
92 | 138 | | |
---|
93 | 139 | | 2. Charge a pharmacist or phar macy a fee related to the |
---|
94 | 140 | | adjudication of a claim including without limitation a fee for: |
---|
95 | 141 | | a. the submission of a claim, |
---|
96 | 142 | | b. enrollment or participation in a retail pharmacy |
---|
97 | 143 | | network, or |
---|
98 | 144 | | c. the development or management of claims processing |
---|
99 | 145 | | services or claims payment services related to |
---|
100 | 146 | | participation in a retail pharmacy network; |
---|
101 | 147 | | 3. Reimburse a pharmacy or pharmacist in the state an amount |
---|
102 | 148 | | less than the amount that the PBM reimburses a phar macy owned by or |
---|
103 | 149 | | under common ownership with a PBM for providing the s ame covered |
---|
104 | 150 | | services. The reimbursement amount paid to the pharmacy shall be |
---|
105 | 151 | | equal to the reimbursement amount calculated on a per-unit basis |
---|
106 | 152 | | using the same generic product identifier or generic code number |
---|
107 | 153 | | paid to the PBM-owned or PBM-affiliated pharmacy; |
---|
108 | 154 | | 4. Deny a provider the opportunity to participate in any |
---|
109 | 155 | | pharmacy network at preferred participation status if the provider |
---|
110 | 156 | | is willing to accept the terms and conditions that the PBM has |
---|
111 | 157 | | established for other providers as a condition of preferred networ k |
---|
112 | 158 | | participation status; |
---|
113 | 159 | | 5. Deny, limit or terminate a provider’s contract based on |
---|
114 | 160 | | employment status of a ny employee who has an active license to |
---|
115 | 161 | | dispense, despite probation status, wi th the State Board of |
---|
116 | 162 | | Pharmacy; |
---|
117 | 163 | | |
---|
120 | 190 | | 2 |
---|
121 | 191 | | 3 |
---|
122 | 192 | | 4 |
---|
123 | 193 | | 5 |
---|
124 | 194 | | 6 |
---|
125 | 195 | | 7 |
---|
126 | 196 | | 8 |
---|
127 | 197 | | 9 |
---|
128 | 198 | | 10 |
---|
129 | 199 | | 11 |
---|
130 | 200 | | 12 |
---|
131 | 201 | | 13 |
---|
132 | 202 | | 14 |
---|
133 | 203 | | 15 |
---|
134 | 204 | | 16 |
---|
135 | 205 | | 17 |
---|
136 | 206 | | 18 |
---|
137 | 207 | | 19 |
---|
138 | 208 | | 20 |
---|
139 | 209 | | 21 |
---|
140 | 210 | | 22 |
---|
141 | 211 | | 23 |
---|
142 | 212 | | 24 |
---|
143 | 213 | | |
---|
144 | 214 | | 6. Retroactively deny or reduce reimbu rsement for a covered |
---|
145 | 215 | | service claim after returning a paid claim response as part of the |
---|
146 | 216 | | adjudication of the claim, unless: |
---|
147 | 217 | | a. the original claim was submitted fraudulently, or |
---|
148 | 218 | | b. to correct errors identified in an audit, so long as |
---|
149 | 219 | | the audit was conducted in compliance with Sections |
---|
150 | 220 | | 356.2 and 356.3 of Title 59 of the Oklahoma Statutes; |
---|
151 | 221 | | 7. Fail to make any payment due to a pharmacy or pharmacist for |
---|
152 | 222 | | covered services properly re ndered in the event a PBM terminates a |
---|
153 | 223 | | provider from a pharmacy benefits manager network; |
---|
154 | 224 | | 8. Conduct or practice spread pricing, as defined in Section 1 |
---|
155 | 225 | | 6960 of this act title, in this state; or |
---|
156 | 226 | | 9. Charge a pharmacist or pharmacy a fee related to |
---|
157 | 227 | | participation in a retail pharmacy network including but not limited |
---|
158 | 228 | | to the following: |
---|
159 | 229 | | a. an application fee, |
---|
160 | 230 | | b. an enrollment or participation fee, |
---|
161 | 231 | | c. a credentialing or re-credentialing fee, |
---|
162 | 232 | | d. a change of ownership fee, or |
---|
163 | 233 | | e. a fee for the development or management of claims |
---|
164 | 234 | | processing services or claims payment services . |
---|
165 | 235 | | C. The prohibitions under this section shall apply to contracts |
---|
166 | 236 | | between pharmacy benefits managers and providers for participation |
---|
167 | 237 | | in retail pharmacy networks. |
---|
168 | 238 | | |
---|
171 | 265 | | 2 |
---|
172 | 266 | | 3 |
---|
173 | 267 | | 4 |
---|
174 | 268 | | 5 |
---|
175 | 269 | | 6 |
---|
176 | 270 | | 7 |
---|
177 | 271 | | 8 |
---|
178 | 272 | | 9 |
---|
179 | 273 | | 10 |
---|
180 | 274 | | 11 |
---|
181 | 275 | | 12 |
---|
182 | 276 | | 13 |
---|
183 | 277 | | 14 |
---|
184 | 278 | | 15 |
---|
185 | 279 | | 16 |
---|
186 | 280 | | 17 |
---|
187 | 281 | | 18 |
---|
188 | 282 | | 19 |
---|
189 | 283 | | 20 |
---|
190 | 284 | | 21 |
---|
191 | 285 | | 22 |
---|
192 | 286 | | 23 |
---|
193 | 287 | | 24 |
---|
194 | 288 | | |
---|
195 | 289 | | 1. A PBM contract shall: |
---|
196 | 290 | | a. not restrict, directly or indirectly, any pharmacy |
---|
197 | 291 | | that dispenses a prescription drug from informing, or |
---|
198 | 292 | | penalize such pharmacy for informing, an indivi dual of |
---|
199 | 293 | | any differential between the individual’s out-of- |
---|
200 | 294 | | pocket cost or coverage with respect to acquisition of |
---|
201 | 295 | | the drug and the amount an individual would pay to |
---|
202 | 296 | | purchase the drug directly, and |
---|
203 | 297 | | b. ensure that any entity t hat provides pharmacy benefits |
---|
204 | 298 | | management services under a contract with any such |
---|
205 | 299 | | health plan or health insurance coverage does not, |
---|
206 | 300 | | with respect to such plan or coverage, restrict, |
---|
207 | 301 | | directly or indirectly, a pharmacy that dispenses a |
---|
208 | 302 | | prescription drug from inf orming, or penalize such |
---|
209 | 303 | | pharmacy for informing, a covered individu al of any |
---|
210 | 304 | | differential between the individual ’s out-of-pocket |
---|
211 | 305 | | cost under the plan or coverage with respect to |
---|
212 | 306 | | acquisition of the drug and t he amount an individual |
---|
213 | 307 | | would pay for acquisit ion of the drug without using |
---|
214 | 308 | | any health plan or health insurance coverage. |
---|
215 | 309 | | 2. A pharmacy benefits manager ’s contract with a provider shall |
---|
216 | 310 | | not prohibit, restrict or limit disclosure of information to the |
---|
217 | 311 | | Attorney General, law enforcement or state and federal governmental |
---|
218 | 312 | | officials investigating or examining a c omplaint or conducting a |
---|
219 | 313 | | |
---|
222 | 340 | | 2 |
---|
223 | 341 | | 3 |
---|
224 | 342 | | 4 |
---|
225 | 343 | | 5 |
---|
226 | 344 | | 6 |
---|
227 | 345 | | 7 |
---|
228 | 346 | | 8 |
---|
229 | 347 | | 9 |
---|
230 | 348 | | 10 |
---|
231 | 349 | | 11 |
---|
232 | 350 | | 12 |
---|
233 | 351 | | 13 |
---|
234 | 352 | | 14 |
---|
235 | 353 | | 15 |
---|
236 | 354 | | 16 |
---|
237 | 355 | | 17 |
---|
238 | 356 | | 18 |
---|
239 | 357 | | 19 |
---|
240 | 358 | | 20 |
---|
241 | 359 | | 21 |
---|
242 | 360 | | 22 |
---|
243 | 361 | | 23 |
---|
244 | 362 | | 24 |
---|
245 | 363 | | |
---|
246 | 364 | | review of a pharmacy benefits manager ’s compliance with the |
---|
247 | 365 | | requirements under the Patient’s Right to Pharmacy Choice Act. |
---|
248 | 366 | | D. A pharmacy benefits manager shall: |
---|
249 | 367 | | 1. Establish and maintain an elect ronic claim inquiry |
---|
250 | 368 | | processing system using the National Council for Prescription Drug |
---|
251 | 369 | | Programs’ current standards to communicate information to pharmacies |
---|
252 | 370 | | submitting claim inquiries; |
---|
253 | 371 | | 2. Fully disclose to insurer s, self-funded employers, unions or |
---|
254 | 372 | | other PBM clients the existence of the re spective aggregate |
---|
255 | 373 | | prescription drug discounts, rebates rece ived from drug |
---|
256 | 374 | | manufacturers and pharmacy audit recoupments; |
---|
257 | 375 | | 3. Provide the Attorney General, insurers, self-funded employer |
---|
258 | 376 | | plans and unions unrestricted audi t rights of and access to the |
---|
259 | 377 | | respective PBM pharmaceutical manufacturer and provider contracts, |
---|
260 | 378 | | plan utilization data, plan pricing data, pharmacy utilization dat a |
---|
261 | 379 | | and pharmacy pricing data; |
---|
262 | 380 | | 4. Maintain, for no less than three (3) years, documentation of |
---|
263 | 381 | | all network development activities including but not limited to |
---|
264 | 382 | | contract negotiations and any denials to providers to join networks. |
---|
265 | 383 | | This documentation shall be made available to th e Attorney General |
---|
266 | 384 | | upon request; |
---|
267 | 385 | | 5. Report to the Attorney General, on a quarterly basis for |
---|
268 | 386 | | each health insurer payor, on the following information: |
---|
269 | 387 | | a. the aggregate amount of rebates received by t he PBM, |
---|
270 | 388 | | |
---|
273 | 415 | | 2 |
---|
274 | 416 | | 3 |
---|
275 | 417 | | 4 |
---|
276 | 418 | | 5 |
---|
277 | 419 | | 6 |
---|
278 | 420 | | 7 |
---|
279 | 421 | | 8 |
---|
280 | 422 | | 9 |
---|
281 | 423 | | 10 |
---|
282 | 424 | | 11 |
---|
283 | 425 | | 12 |
---|
284 | 426 | | 13 |
---|
285 | 427 | | 14 |
---|
286 | 428 | | 15 |
---|
287 | 429 | | 16 |
---|
288 | 430 | | 17 |
---|
289 | 431 | | 18 |
---|
290 | 432 | | 19 |
---|
291 | 433 | | 20 |
---|
292 | 434 | | 21 |
---|
293 | 435 | | 22 |
---|
294 | 436 | | 23 |
---|
295 | 437 | | 24 |
---|
296 | 438 | | |
---|
297 | 439 | | b. the aggregate amount of rebates distributed to the |
---|
298 | 440 | | appropriate health in surer payor, |
---|
299 | 441 | | c. the aggregate amount of rebates passed on to the |
---|
300 | 442 | | enrollees of each healt h insurer payor at the point of |
---|
301 | 443 | | sale that reduced the applicable deductible, |
---|
302 | 444 | | copayment, coinsure or other cost sharing amount of |
---|
303 | 445 | | the enrollee, |
---|
304 | 446 | | d. the individual and agg regate amount paid by t he health |
---|
305 | 447 | | insurer payor to the PBM for pharmacy services |
---|
306 | 448 | | itemized by pharmacy, drug product and service |
---|
307 | 449 | | provided, and |
---|
308 | 450 | | e. the individual and aggreg ate amount a PBM paid a |
---|
309 | 451 | | provider for pharmac y services itemized by pharmacy, |
---|
310 | 452 | | drug product and service provide d; and |
---|
311 | 453 | | 6. Maintain a fiduciary duty to insurers and insured s served by |
---|
312 | 454 | | the PBM. |
---|
313 | 455 | | SECTION 2. This act shall become effective November 1, 2024. |
---|